Pyridam Farma (Indonesia) Today
| PYFA Stock | IDR 236.00 8.00 3.28% |
Performance11 of 100
| Odds Of DistressLess than 30
|
Pyridam Farma is selling for 236.00 as of the 13th of December 2024. This is a 3.28 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 234.0. Pyridam Farma has about a 30 percent probability of financial distress in the next few years of operation but had a somewhat good performance during the last 90 days. The performance scores are derived for the period starting the 19th of December 2023 and ending today, the 13th of December 2024. Click here to learn more.
Moving together with Pyridam Stock
Moving against Pyridam Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Pyridam Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Pyridam Farma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Pyridam Farma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Pharmaceuticals (View all Sectors) |
Pyridam Farma Tbk (PYFA) is traded on Jakarta Exchange in Indonesia and employs 1,163 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 452.14 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pyridam Farma's market, we take the total number of its shares issued and multiply it by Pyridam Farma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Pyridam Farma Tbk has 535.08 M outstanding shares.
Pyridam Farma generates positive cash flow from operations, but has no cash available
Check Pyridam Farma Probability Of Bankruptcy
Ownership AllocationPyridam Farma owns a total of 535.08 Million outstanding shares. Pyridam Farma has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Pyridam Ownership Details
Pyridam Farma Tbk Risk Profiles
Although Pyridam Farma's alpha and beta are two of the key measurements used to evaluate Pyridam Farma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 4.44 | |||
| Semi Deviation | 3.54 | |||
| Standard Deviation | 6.25 | |||
| Variance | 39.09 |
Pyridam Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Pyridam Farma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Pyridam Farma Corporate Management
Elected by the shareholders, the Pyridam Farma's board of directors comprises two types of representatives: Pyridam Farma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pyridam. The board's role is to monitor Pyridam Farma's management team and ensure that shareholders' interests are well served. Pyridam Farma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pyridam Farma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Nadia Verdiana | Head Sec | Profile | |
| Yoshiana | Head Unit | Profile | |
| Joshua Sandjaja | HRD Mang | Profile | |
| Andrey Septiana | Head OTC | Profile | |
| Yenfrino Gunadi | CFO Director | Profile | |
| Sinta Ningsih | Accounting, Fin | Profile | |
| Yan Lee | Pres Director | Profile |
Other Information on Investing in Pyridam Stock
Pyridam Farma financial ratios help investors to determine whether Pyridam Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pyridam with respect to the benefits of owning Pyridam Farma security.